"Rapid Pathogen Screening, Inc. - Product Pipeline Analysis, 2013 Update" Is Now Available at Fast Market Research
Rapid Pathogen Screening, Inc. (Rapid Pathogen) is a biotechnology company. The company is a developer, and marketer of rapid, point-of-care (POC) diagnostic tests. It uses its patented Direct Sampling Micro-Filtration (DSMF) and Direct Multi-Planar Chromafiltography (DMC) technology. Rapid Pathogen also uses diagnostic tools a enabling on time treatment for clinicians to give to patients. The company's products include InflammaDry available in Europe, and AdenoPlus, which is available in the US. Its business offices with its biosafety level 2 (BSL-2) laboratories...
View full press release